A Population-Based Descriptive Atlas of Invasive Pneumococcal Strains Recovered Within the U.S. During 2015–2016

Overview of attention for article published in Frontiers in Microbiology, November 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Altmetric has seen 19 news stories from 19 outlets.

Pfizer Inc. (NYSE: PFE) gab heute bekannt, dass die Europäische Kommission (EK) die Marktzulassung für den 20-valenten…

ファイザー株式会社 (NYSE:PFE) は本日、欧州委員会 (EC) が、欧州連合内でブランド名 PREVENAR 20® で販売されている同社の 20 価肺炎球菌結合型ワクチンについて、予防のための能動免疫として販売承認を付与したと発表しました。生後6週…

Pfizer Inc. (NYSE: PFE) today announced that the European Commission (EC) has granted marketing authorization for the company's…

PREVENAR 20® (20-valent Pneumococcal Conjugate Vaccine) offers the broadest serotype coverage of any pediatric pneumococcal…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 15 additional news stories.